Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2014, Article ID 714273, 7 pages
http://dx.doi.org/10.1155/2014/714273
Research Article

Characterization of Diabetic Neuropathy in the Zucker Diabetic Sprague-Dawley Rat: A New Animal Model for Type 2 Diabetes

1Department of Internal Medicine, The University of Iowa, Iowa City, IA 52242, USA
2Department of Veterans Affairs Iowa City Health Care System, Iowa City, IA 52246, USA
3PreClinOmics Inc., Indianapolis, IN 46268, USA
4Iowa City Veterans Administration Center for the Prevention and Treatment of Visual Loss, Iowa City, IA 52246, USA
5Fraternal Order of Eagles Diabetes Research Center, University of Iowa, Iowa City, IA 52242, USA

Received 23 July 2014; Accepted 9 September 2014; Published 13 October 2014

Academic Editor: Norman Cameron

Copyright © 2014 Eric P. Davidson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. Clark, C. J. Palmer, and W. N. Shaw, “The diabetic Zucker fatty rat,” Proceedings of the Society for Experimental Biology and Medicine, vol. 173, no. 1, pp. 68–75, 1983. View at Publisher · View at Google Scholar · View at Scopus
  2. R. G. Peterson, W. N. Shaw, M. A. Neel, L. A. Little, and J. Eichberg, “Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus,” ILAR News, vol. 32, pp. 16–19, 1990. View at Google Scholar
  3. R. G. Peterson, M. A. Neel, L. A. Little, J. C. Kincaid, and J. Eichberg, “Neuropathic complications in the Zucker diabetic fatty rat (ZDF/ Drt-fa),” in Frontiers in Diabetes Research. Lessons From Animal Diabetes III, E. Shafrir, Ed., pp. 456–458, Smith-Gordon, London, UK, 1990. View at Google Scholar
  4. E. Shafrir, “Animal models of non-insulin-dependent diabetes,” Diabetes/Metabolism Reviews, vol. 8, no. 3, pp. 179–208, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. L. J. Coppey, J. S. Gellett, E. P. Davidson, J. A. Dunlap, and M. A. Yorek, “Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats,” Diabetes/Metabolism Research and Reviews, vol. 18, no. 1, pp. 49–56, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. C. L. Oltman, L. J. Coppey, J. S. Gellett, E. P. Davidson, D. D. Lund, and M. A. Yorek, “Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 289, no. 1, pp. E113–E122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. C. L. Oltman, E. P. Davidson, L. J. Coppey et al., “Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverse,” Diabetes, Obesity and Metabolism, vol. 10, no. 1, pp. 64–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. L. J. Coppey, J. S. Gellett, and M. A. Yorek, “Mediation of vascular relaxation in epineurial arterioles of the sciatic nerve: effect of diabetes in type 1 and type 2 diabetic rat models,” Endothelium: Journal of Endothelial Cell Research, vol. 10, no. 2, pp. 89–94, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Reinwald, R. G. Peterson, M. R. Allen, and D. B. Burr, “Skeletal changes associated with the onset of type 2 diabetes in the ZDF and ZDSD rodent models,” American Journal of Physiology: Endocrinology and Metabolism, vol. 296, no. 4, pp. E765–E774, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. E. Davis, J. Cain, W. J. Banz, and R. G. Peterson, “Age-related differences in response to high-fat feeding on adipose tissue and metabolic profile in ZDSD rats,” ISRN Obesity, vol. 2013, Article ID 584547, 8 pages, 2013. View at Publisher · View at Google Scholar
  11. J. Bełtowski, “Leptin and the regulation of endothelial function in physiological and pathological conditions,” Clinical and Experimental Pharmacology and Physiology, vol. 39, no. 2, pp. 168–178, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Kaur, “A comprehensive review on metabolic syndrome,” Cardiology Research and Practice, vol. 2014, Article ID 943162, 21 pages, 2014. View at Publisher · View at Google Scholar
  13. R. Ricci and F. Bevilacqua, “The potential role of leptin and adiponectin in obesity: a comparative review,” Veterinary Journal, vol. 191, no. 3, pp. 292–298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Duvnjak and M. Duvnjak, “The metabolic syndrome—an ongoing story,” Journal of Physiology and Pharmacology, vol. 60, pp. 19–24, 2009. View at Google Scholar · View at Scopus
  15. W. Gade, J. Schmit, M. Collins, and J. Gade, “Beyond obesity: the diagnosis and pathophysiology of metabolic syndrome,” Clinical Laboratory Science, vol. 23, no. 1, pp. 51–65, 2010. View at Google Scholar · View at Scopus
  16. E. P. Davidson, L. J. Coppey, N. A. Calcutt, C. L. Oltman, and M. A. Yorek, “Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 4, pp. 306–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. E. P. Davidson, L. J. Coppey, A. Holmes, B. Dake, and M. A. Yorek, “Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications,” European Journal of Pharmacology, vol. 668, no. 3, pp. 497–506, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. E. P. Davidson, L. J. Coppey, A. Holmes, and M. A. Yorek, “Changes in corneal innervation and sensitivity and acetylcholine-mediated vascular relaxation of the posterior ciliary artery in a type 2 diabetic rat,” Investigative Ophthalmology and Visual Science, vol. 53, no. 3, pp. 1182–1187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Quattrini, M. Tavakoli, M. Jeziorska et al., “Surrogate markers of small fiber damage in human diabetic neuropathy,” Diabetes, vol. 56, no. 8, pp. 2148–2154, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Tavakoli, C. Quattrini, C. Abbott et al., “Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy,” Diabetes Care, vol. 33, no. 8, pp. 1792–1797, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. J. Coppey, E. P. Davidson, J. A. Dunlap, D. D. Lund, and M. A. Yorek, “Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve,” Experimental Diabesity Research, vol. 1, no. 2, pp. 131–143, 2000. View at Google Scholar · View at Scopus
  22. K. Terata, L. J. Coppey, E. P. Davidson, J. A. Dunlap, D. D. Gutterman, and M. A. Yorek, “Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction,” British Journal of Pharmacology, vol. 128, no. 3, pp. 837–843, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. L. J. Coppey, A. Holmes, E. P. Davidson, and M. A. Yorek, “Partial replacement with menhaden oil improves peripheral neuropathy in high-fat-fed low-dose streptozotocin type 2 diabetic rat,” Journal of Nutrition and Metabolism, vol. 2012, Article ID 950517, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Lupachyk, P. Watcho, H. Shevalye et al., “Na+/H+exchanger 1 inhibition reverses manifestation of peripheral diabetic neuropathy in type 1 diabetic rats,” American Journal of Physiology—Endocrinology and Metabolism, vol. 305, no. 3, pp. E396–E404, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. K. K. Beiswenger, N. A. Calcutt, and A. P. Mizisin, “Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice,” Neuroscience Letters, vol. 442, no. 3, pp. 267–272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Lauria, R. Lombardi, M. Borgna et al., “Intraepidermal nerve fiber density in rat foot pad: neuropathologic- neurophysiologic correlation,” Journal of the Peripheral Nervous System, vol. 10, no. 2, pp. 202–208, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Strom, J. Brüggemann, I. Ziegler et al., “Pronounced reduction of cutaneous langerhans cell density in recently diagnosed type 2 diabetes,” Diabetes, vol. 63, no. 3, pp. 1148–1153, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Ziegler, N. Papanas, A. Zhivov et al., “Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes,” Diabetes, vol. 63, no. 7, pp. 2454–2463, 2014. View at Publisher · View at Google Scholar
  29. K. K. Beiswenger, N. A. Calcutt, and A. P. Mizisin, “Epidermal nerve fiber quantification in the assessment of diabetic neuropathy,” Acta Histochemica, vol. 110, no. 5, pp. 351–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Brussee, G. Guo, Y. Dong et al., “Distal degenerative sensory neuropathy in a long-term type 2 diabetes rat model,” Diabetes, vol. 57, no. 6, pp. 1664–1673, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. E. P. Davidson, L. J. Coppey, R. H. Kardon, and M. A. Yorek, “Differences and similarities in development of corneal nerve damage and peripheral neuropathy and in diet- induced obesity and type 2 diabetic rats,” Investigative Ophthalmology and Visual Science, vol. 55, no. 3, pp. 1222–1230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. Yorek, L. J. Coppey, J. S. Gellett, and E. P. Davidson, “Sensory nerve innervation of epineurial arterioles of the sciatic nerve containing calcitonin gene-related peptide: effect of streptozotocin-induced diabetes,” Experimental Diabesity Research, vol. 5, no. 3, pp. 187–193, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. E. P. Davidson, L. J. Coppey, T. L. Kleinschmidt, C. L. Oltman, and M. A. Yorek, “Vascular and neural dysfunctions in obese Zucker rats: effect of AVE7688,” Experimental Diabetes Research, vol. 2009, Article ID 912327, 8 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. C. L. Oltman, L. L. Richou, E. P. Davidson, L. J. Coppey, D. D. Lund, and M. A. Yorek, “Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 291, no. 4, pp. H1780–H1787, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. C. L. Oltman, T. L. Kleinschmidt, E. P. Davidson, L. J. Coppey, D. D. Lund, and M. A. Yorek, “Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes,” Vascular Pharmacology, vol. 48, no. 1, pp. 47–53, 2008. View at Publisher · View at Google Scholar · View at Scopus